Gulf International Bank (Uk) LTD Amgen Inc Transaction History

Gulf International Bank (Uk) LTD

  • $3.9 Billion
  • Q3 2024

A detailed history of Gulf International Bank (Uk) LTD transactions in Amgen Inc stock. As of the latest transaction made, Gulf International Bank (Uk) LTD holds 42,322 shares of AMGN stock, worth $11.1 Million. This represents 0.35% of its overall portfolio holdings.

Number of Shares
42,322
Previous 44,096 4.02%
Holding current value
$11.1 Million
Previous $13.8 Million 1.02%
% of portfolio
0.35%
Previous 0.35%

Shares

26 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 30, 2024
SELL
$309.38 - $337.38 $548,840 - $598,512
-1,774 Reduced 4.02%
42,322 $13.6 Million
Q2 2024

Jul 10, 2024
SELL
$262.75 - $319.31 $557,292 - $677,256
-2,121 Reduced 4.59%
44,096 $13.8 Million
Q1 2024

Apr 11, 2024
BUY
$268.87 - $324.56 $612,754 - $739,672
2,279 Added 5.19%
46,217 $13.1 Million
Q4 2023

Jan 11, 2024
SELL
$255.7 - $288.46 $1.25 Million - $1.42 Million
-4,908 Reduced 10.05%
43,938 $12.7 Million
Q3 2023

Oct 10, 2023
SELL
$218.65 - $271.46 $1.12 Million - $1.39 Million
-5,136 Reduced 9.51%
48,846 $13.1 Million
Q2 2023

Aug 02, 2023
SELL
$214.27 - $253.37 $3.49 Million - $4.13 Million
-16,305 Reduced 23.2%
53,982 $12 Million
Q1 2023

Apr 12, 2023
SELL
$225.79 - $275.2 $4.7 Million - $5.73 Million
-20,834 Reduced 22.86%
70,287 $17 Million
Q3 2022

Oct 07, 2022
SELL
$224.46 - $253.15 $1.32 Million - $1.49 Million
-5,878 Reduced 6.06%
91,121 $20.5 Million
Q2 2022

Jul 19, 2022
SELL
$230.71 - $256.74 $156,190 - $173,812
-677 Reduced 0.69%
96,999 $23.6 Million
Q4 2021

Jan 24, 2022
SELL
$198.88 - $227.6 $3.93 Million - $4.5 Million
-19,751 Reduced 16.82%
97,676 $22 Million
Q3 2021

Nov 10, 2021
SELL
$212.27 - $248.7 $67,289 - $78,837
-317 Reduced 0.27%
117,427 $25 Million
Q2 2021

Aug 10, 2021
SELL
$233.58 - $259.14 $106,512 - $118,167
-456 Reduced 0.39%
117,744 $28.7 Million
Q1 2021

May 14, 2021
SELL
$221.91 - $258.6 $2.93 Million - $3.42 Million
-13,222 Reduced 10.06%
118,200 $29.4 Million
Q4 2020

Feb 12, 2021
SELL
$216.38 - $257.67 $2.11 Million - $2.52 Million
-9,774 Reduced 6.92%
131,422 $30.2 Million
Q3 2020

Oct 21, 2020
SELL
$234.65 - $260.95 $319,124 - $354,892
-1,360 Reduced 0.95%
141,196 $35.9 Million
Q2 2020

Jul 24, 2020
BUY
$197.81 - $242.74 $201,172 - $246,866
1,017 Added 0.72%
142,556 $33.6 Million
Q1 2020

May 12, 2020
SELL
$182.24 - $241.7 $97,680 - $129,551
-536 Reduced 0.38%
141,539 $28.7 Million
Q4 2019

Feb 05, 2020
SELL
$189.21 - $243.2 $742,649 - $954,560
-3,925 Reduced 2.69%
142,075 $34.3 Million
Q3 2019

Oct 08, 2019
SELL
$174.11 - $208.62 $364,586 - $436,850
-2,094 Reduced 1.41%
146,000 $28.3 Million
Q2 2019

Jul 10, 2019
SELL
$166.7 - $195.41 $882,843 - $1.03 Million
-5,296 Reduced 3.45%
148,094 $27.3 Million
Q1 2019

Apr 18, 2019
SELL
$180.87 - $203.88 $78,859 - $88,891
-436 Reduced 0.28%
153,390 $29.1 Million
Q4 2018

Jan 08, 2019
SELL
$178.4 - $208.25 $12.6 Million - $14.7 Million
-70,765 Reduced 31.51%
153,826 $29.9 Million
Q3 2018

Nov 05, 2018
BUY
$185.29 - $208.89 $1.28 Million - $1.44 Million
6,912 Added 3.18%
224,591 $46.6 Million
Q2 2018

Jul 05, 2018
BUY
$166.05 - $186.51 $805,508 - $904,760
4,851 Added 2.28%
217,679 $40.2 Million
Q1 2018

May 09, 2018
SELL
$169.43 - $198.0 $3.35 Million - $3.91 Million
-19,743 Reduced 8.49%
212,828 $36.3 Million
Q3 2017

Oct 11, 2017
BUY
$167.29 - $191.0 $38.9 Million - $44.4 Million
232,571
232,571 $43.4 Million

Others Institutions Holding AMGN

# of Institutions
3,125
Shares Held
409M
Call Options Held
7.56M
Put Options Held
7.2M
View Full List

About AMGEN INC

AMGN Quotes by TradingView
  • Ticker AMGN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 534,931,008
  • Market Cap $141B
  • Description
  • Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...
More about AMGN
Track This Portfolio

Track Gulf International Bank (Uk) LTD Portfolio

Follow Gulf International Bank (Uk) LTD and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Gulf International Bank (Uk) LTD, based on Form 13F filings with the SEC.

News

Stay updated on Gulf International Bank (Uk) LTD with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email